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Abstract
MicroRNAs comprise a family of small non-coding RNAs that modulate several developmental and physiological processes
including pregnancy. Their ubiquitous presence is confirmed in mammals, worms, flies and plants. Although rapid advances
have been made in microRNA research, information on stable reference genes for validation of microRNA expression is still
lacking. Real time PCR is a widely used tool to quantify gene transcripts. An appropriate reference gene must be chosen to
minimize experimental error in this system. A small difference in miRNA levels between experimental samples can be
biologically meaningful as these entities can affect multiple targets in a pathway. This study examined the suitability of six
commercially available reference genes (RNU1A, RNU5A, RNU6B, SNORD25, SCARNA17, and SNORA73A) in maternal-fetal
tissues from healthy and spontaneously arresting/dying conceptuses from sows were separately analyzed at gestation day
20. Comparisons were also made with non-pregnant endometrial tissues from sows. Spontaneous fetal loss is a prime
concern to the commercial pork industry. Our laboratory has previously identified deficits in vasculature development at
maternal-fetal interface as one of the major participating causes of fetal loss. Using this well-established model, we have
extended our studies to identify suitable microRNA reference genes. A methodical approach to assessing suitability was
adopted using standard curve and melting curve analysis, PCR product sequencing, real time PCR expression in a panel of
gestational tissues, and geNorm and NormFinder analysis. Our quantitative real time PCR analysis confirmed expression of
all 6 reference genes in maternal and fetal tissues. All genes were uniformly expressed in tissues from healthy and
spontaneously arresting conceptus attachment sites. Comparisons between tissue types (maternal/fetal/non-pregnant)
revealed significant differences for RNU5A, RNU6B, SCARNA17, and SNORA73A expression. Based on our methodical
assessment of all 6 reference genes, results suggest that RNU1A is the most stable reference gene for porcine pregnancy
studies.
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Introduction
MicroRNAs (miRNAs) are a recently discovered class of bio-
regulatory, short, non-coding molecules that bind to target
messenger RNAs (mRNAs) and repress their translation. This is
achieved by physically inhibiting translation of the mRNA or
through its degradation [1,2]. MiRNAs participate in various
biological processes [3, Reviewed in: 4–7] and miRNA profiles
may be more accurate predictors of disease classification than
mRNA profiles [8].
Real time PCR is a sensitive method of measuring gene
transcript levels in biological systems. It has recently become a
popular method of measuring miRNA expression [9–18]. Relative
quantification is the preferred method of quantification as absolute
quantification has the potential to contain multiple measurement
errors. To minimize experimental errors which may occur at any
step of the RNA to cDNA to PCR transition or between PCR
runs, relative quantification employs a reference gene to normalize
the measurement of transcript levels in experimental samples. As
miRNA gene expression profiling is an emerging methodology,
few reports have been published which identify suitable reference
genes for real time PCR studies.
Reference, control, or housekeeping genes as they are also
known are genes which express transcripts at uniform levels. The
ideal reference gene is constitutively expressed at consistent levels
in all samples, tissue types (including physiological and patholog-
ical specimens), and altered experimental conditions. Relative
quantification creates a ratio of the number of transcripts of a gene
of interest with the number of transcripts of the unchanging
reference gene within the same sample. This allows samples from
different individuals to be more accurately compared because
sample variation is standardized. Thus, samples of different
qualities, of differing amounts of cDNA, or from different PCR
runs can be compared. Unfortunately the expression of many
reference genes does change in different tissue types and under
different experimental conditions [10,19–21]. As the difference in
miRNA levels between experimental samples can be very small,
yet still biologically meaningful [10,22], choosing an unstable
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28940reference gene has the potential to mask significant differences
[10,22]. The selection and validation of an appropriate reference
gene for every experiment is of paramount importance.
During early gestation in the pig a large number of conceptuses
spontaneously arrest [23–25]. This presents a challenge when
selecting a miRNA reference gene as there are four physiologically
and pathologically distinct types of tissues (maternal endometrium
and fetal trophoblast associated with healthy conceptus, maternal
endometrium and fetal trophoblast associated with arresting or
dying conceptuses) present in the same pregnant uterus. This study
aims to determine the suitability of six potential reference genes for
miRNA quantification by real time PCR during early gestation in
the pig. These six genes were selected because human miRNA
primers which had been demonstrated effective in other species
(mouse, rat, and dog) were commercially available. This is the first
report outlining a methodological assessment of several snRNA
and snoRNA reference genes for miRNA expression studies in the
pig. As such, the methods and results provide useful information
and insight to any researcher intent on quantifying miRNAs in
other species.
Results
Strategy for the Assessment of Reference Genes
A list of requirements was generated to help select the best
reference gene (listed in Table 1) for measuring miRNA expression
during early gestation in the pig. The most appropriate gene(s)
should have: 1) a PCR efficiency close to 2 (within 80–100%), 2) a
standard curve where 10-fold dilutions have crossing points (Cps)
approximately 2.5 cycles apart, 3) a narrow range of Cp/no
significant differences in Cps across the tissues of interest, 4) a single
melting peak and melting temperature of approximately 74–77uC,
5) its sequence confirmed by sequencing the PCR product, 6) its
product sizeconfirmed bygelelectrophoresis,7)anMvalue of#1.5
as determined by geNorm software [26], 8) low inter- and intra-
group variation and stability value as determined by NormFinder
software [27], and 9) a standard error of mean (SEM).
Real Time PCR, Cloning and Sequencing of Candidate
Reference Genes
Standard curves (10-fold dilution) were generated and opti-
mized for each reference gene (Figure 1A, 1B, 1D, 1E, 1G, 1H, 1J,
1K, 1M, 1N, 1P, 1Q) by plate-based real time PCR. All candidate
genes had adjusted PCR efficiencies within the 80–100% range,
with SCARNA17 having the greatest efficiency (Table 2). Out of the
six candidate genes, the standard curves for RNU1A and SNORD25
were closest to having Cps approximately 2.5 cycles apart
(Figure 1A, 1J). Melting curves were generated and specific
melting temperatures for each gene were calculated (Figure 1C,
1F, 1I, 1L, 1O, 1R), (Table 2). RNU1A, SCARNA17, and
SNORA73A had melting temperatures slightly higher than the kit
manufacturer’s 74–77uC range. No double melting peaks were
observed, indicating a pure PCR product (Figure 1C, 1F, 1I, 1L,
1O, 1R). Of the six candidate genes, five (RNU1A, RNU5A,
RNU6B, SNORD25, and SCARNA17) were successfully cloned,
sequenced, and identified as the correct gene using NCBI BLAST
analysis. SNORA73A could not be cloned, even after three
attempts. All six PCR products were run on an agarose gel, and
product sizes were within the expected 100–150 bp range [data
not shown].
Measurement of Reference Gene Expression in a Panel of
Experimental Samples
Plate-based real time PCR was used to measure the expression
of all six reference genes in a panel of sixteen samples which
included five tissue types (healthy maternal endometrium (HE),
healthy fetal trophoblast (HT), arresting maternal endometrium
(AE), arresting fetal trophoblast (AT), and non-pregnant endome-
trium (NP)) (Figure 2). Cp values were measured in duplicate by
Roche LightCycler software. The six reference genes displayed a
wide range of Cp values from 11.25 (RNU1A) to 32.36 (SNORD25).
Both SNORD25 and SCARNA17 had low levels of expression,
whereas RNU1A, RNU5A, RNU6B and SNORA73A had high levels
of expression (Figure 2). The Cp range for each gene was
calculated by subtracting the lowest Cp value from the highest Cp
value. RNU6B had the narrowest range (Table 2).
Mean amplification Cps and SEM were calculated for each
tissue type, and data was compared by one-way ANOVA. The
overall variation between samples of the same tissue type was low,
as was the variability between tissue types. Significant differences
(p,0.05) existed between tissue types for RNU5A, RNU6B,
SCARNA17, and SNORA73A (Figure 2).
Stability of Reference Genes in Reproductive Tissues
The expression stability of all six candidate genes was measured
using two different algorithms which measure variation: geNorm
[26] and NormFinder [27]. GeNorm is a mathematical algorithm
used to select the most stable reference gene from a panel of genes,
wheregeneswithanMvalue#1.5arestablyexpressedgenes.Allsix
candidate genes had M values less than 1.5 (Table 2). RNU1A had
the lowest M value, followed by SNORA73A, SNORD25, RNU6B,
RNU5A,a n dSCARNA17. GeNorm also calculated a V value which
recommended the use of two reference genes (RNU1A and
SNORA73A) for the optimal normalization factor [data not shown].
NormFinder is another algorithm used to select the most stable
reference gene from a panel of genes, where genes with a low
stability value are stably expressed genes. All six genes had stability
values less than 0.4 (Table 2). Remarkably, four out of six genes
followed the same rank order of stability as calculated by geNorm.
The only exception was that the order of RNU6B and RNU5A
stability was reversed. NormFinder also recommended the use of
two reference genes (RNU1A and SNORD25) [data not shown].
However, the stability value of RNU1A combined with SNORD25
was 0.001 lower than that of RNU1A alone. A robust correlation
between the geNorm M value and the NormFinder Stability Value
was found by evaluating by the coefficient of determination (R
2)
(Figure 3).
Effect of Reference Gene Selection on Target Gene
Expression
The effect of reference gene selection on target gene expression
was measured using miR-331-5p and miR-339-3p as target genes. A
Table 1. Candidate Reference Genes.
Short Form Full Name
Estimated Size (bp)
[33]
RNU1A U1 small nuclear RNA 125
RNU5A U5A small nuclear 1 RNA 130
RNU6B U6 small nuclear 2 RNA 100
SNORD25 Small nucleolar RNA, C/D box 25 130
SCARNA17 Small Cajal body-specific RNA 17 125
SNORA73A Small nucleolar RNA, H/ACA box 73A 150
doi:10.1371/journal.pone.0028940.t001
Validation of miRNA Reference Genes
PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e28940Figure 1. Standard Curves and Melting Peaks of Candidate Genes. Standard curves were generated with a 10-fold dilution for each reference
gene (A, D, G, J, M, P). Several dilutions were removed to optimize PCR efficiency (B, E, H, K, N, Q). Melting curve analysis revealed six single peaks, and
different temperatures (C, F, I, L, O, R). Numbers on the graph indicate 10-fold dilutions remaining in the optimized standard curve.
doi:10.1371/journal.pone.0028940.g001
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experimental samples, and determined the expression of both
genes to be equal in HE and HT. Real time PCR was used to
assess the effect a reference gene could have on target
quantification. Each target was quantified to each reference gene
(Figure 4). Significant differences were observed between target
gene expression in HE compared with HT when using SNORD25
(Figure 4A), RNU5A,o rSCARNA17 (Figure 4B) as reference genes.
Selection of an inappropriate reference gene had the ability to
artificially influence the relative quantity of miR-331-5p and miR-
339-3p.
Effect of Two Reference Genes on Target Gene
Expression
The fold change for miR-331-5p and miR-339-3p between HE
and HT were calculated using the geometric mean of RNU1A/
SNORD25 and the ddCt method (Figure 5). When the most stable
pair of references genes as predicted by geNorm and NormFinder
wasusedforquantification,nosignificantdifferenceswereobserved.
Discussion
To allow for the most accurate comparison of miRNA
transcripts, it is imperative to select a reference gene with the
least amount of variation between samples, and tissues. The
optimal gene(s) should be constitutively expressed at similar levels
in all tissues, and not influenced by internal or external factors.
This is particularly important for miRNA expression profiling
because they may be more accurate predictors of disease than
mRNA profiles [8]. Even small differences in miRNA expression
may be biologically significant because miRNAs regulate multiple
targets in a pathway, amplifying their effects [4]. Measuring
Table 2. Summary of Reference Gene Assessment.
Reference
Gene
Raw PCR
Efficiency
Standard Curve
Dilutions Remaining
Adjusted PCR
Efficiency
Melting
Temperature (6C)
Cp
Range
Confirmed by
Sequencing
Product
Size (bp)
Sig.
Diff.
M
Value
Stability
Value
RNU1A 1.647 10
25,1 0
26,1 0
27 1.762=88% 78.49 5.02 Yes ,150 No 0.320 0.143
RNU5A 1.632 10
24,10
25,1 0
26 1.716=86% 75.89 5.33 Yes ,125 Yes 0.521 0.328
RNU6B 1.625 10
25,1 0
26,1 0
27 1.757=88% 76.46 3.82 Yes ,100 Yes 0.418 0.345
SNORD25 1.634 10
25,1 0
26,1 0
27,1 0
28 1.701=85% 77.27 4.38 Yes ,125 No 0.345 0.186
SCARNA17 1.678 10
25,1 0
26,1 0
27,1 0
28 1.855=93% 78.20 5.23 Yes ,150 Yes 0.663 0.383
SNORA73A 0.640 10
24,10
25,1 0
28 1.685=84% 78.25 5.13 No ,150 Yes 0.331 0.153
doi:10.1371/journal.pone.0028940.t002
Figure 2. Real Time PCR Crossing Point Values in Pig Reproductive Tissues. Expression levels of all six candidate genes, shown as the mean
crossing point (Cp) plus SEM for each tissue type. White bars: tissue collected from healthy conceptus attachment sites, black bars: tissue collected
from arresting conceptus attachment sites, grey bars: non-pregnant endometrium. Means were compared by ANOVA and significant differences
(p,0.05) are indicated by different letters above the bars of the graph. If bars have a letter in common, no significant difference exists. For all white
and black bars, n=3. For grey bars, n=4. Endo: endometrium; NP: non-pregnant endometrium; Tropho: Trophoblast.
doi:10.1371/journal.pone.0028940.g002
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drastic errors of measurement [10,11]. Peltier and Latham (2008)
demonstrated that the use of inappropriate reference genes
produced quantitative (magnitude of fold change) and qualitative
(direction of fold change) errors, and even supported with
statistical significance an incorrect conclusion [10]. This reinforces
the need for experiment and tissue-specific validation of reference
genes for miRNA expression studies.
Figure 3. Correlation of M Value and Stability Value. The correlation between the M value calculated by geNorm and Stability Value calculated
by NormFinder was evaluated using the coefficient of determination (R
2).
doi:10.1371/journal.pone.0028940.g003
Figure 4. Importance of Reference Gene Stability on the Relative Quantification of Target Genes. Relative quantification of miR-331-5p
(A) and miR-339-3p (B) with each reference gene in healthy endometrium and trophoblast. Differential expression of miR-331-5p and miR-339-3p is
observed, even though microarray data [data not shown] indicated consistent expression between the tissues. Healthy endometrium (HE) was
compared to healthy trophoblast (HT) independently for each reference gene by t-test. Data are shown as the mean + SEM, on a logarithmic scale.
Dark grey bars: HE (n=3), light grey bars: HT (n=3). Significant differences (p,0.05) between HE and HT are demonstrated by asterisk (*) above the
bars for the reference gene where the significant difference occurred.
doi:10.1371/journal.pone.0028940.g004
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been identified [19–21], even for use in the pig [21,28], no well-
established reference genes for miRNA quantification have been
identified in this species. Human miRNA studies employ various
reference genes including two other small nuclear RNAs RNU48
[12] and RNU44 [18]. However, only a few studies which assess
and validate the use of miRNA reference genes in human disease:
lung cancer [10], breast cancer [12], and colorectal cancer [11]
have been published. Many others have been published prior to
adequate reference validation. It is likely that many miRNA
reference genes other than those tested in this report exist in the
pig. Any reference gene proven effective in another species
qualifies for validation as a miRNA reference gene in the pig.
Of the six reference genes tested in this report, two have been
employed in other studies. RNU1A has been used as a miRNA
reference gene in recently published prostate cancer research
[15,16], and RNU6B in colorectal cancer [17], tumour pathology
[18], erythropoiesis [29], and cell proliferation and growth [30].
Yet, several studies have found RNU6B to be an inappropriate/
unstable reference gene due to its variability [10,31,32]. Our data
also suggests that RNU6B is an inferior choice of reference gene for
miRNA expression profiling during early gestation in the pig
because of its altered expression across tissues. Consistent, reliable,
and validated miRNA reference genes for expression studies in
mammals are absolutely required. This will allow the field of
miRNA research to rapidly advance.
This is the first report detailing the validation of suitable
reference genes for the normalization of miRNA real time PCR
data in pigs. It is also the first to demonstrate the expression of all
six reference genes and two target genes (miR-331-5p, miR-339-3p)
in pigs. Here, we compared six different commercially available
miRNA reference genes in a panel of five pig reproductive tissues.
Selecting an appropriate reference gene for quantification of
miRNAs in reproductive tissues is a challenge as there are four
physiologically and pathologically distinct types of tissues (mater-
nal endometrium and fetal trophoblast associated with healthy
conceptus, maternal endometrium and fetal trophoblast associated
with arresting or dying conceptuses) present in the same pregnant
uterus. Non-pregnant endometrium was added as the fifth tissue as
many comparisons are likely to be made between non-pregnant
and pregnant endometrium to demonstrate the molecular
fingerprint of pregnancy.
In order to determine the suitability of six human miRNA
reference genes in early reproductive tissues in the pig, a strategy for
their assessment was developed to systematically eliminate the more
unstable and inappropriate genes. The first criterion was that the
PCR efficiency was close to 2 (within 80–100%). All six genes tested
had efficiencies within this range. The second criterion was that a
standard curve where 10-fold dilutions with Cps approximately 2.5
cycles apart could be generated. Standard curves for all six genes
were generated, and none of the genes tested had standard curves
which indicated a problem with amplification of the gene transcript.
The third criterion was a narrow range of Cp/no significant
differences in Cps across the tissues of interest. Here, several genes
were deemed inappropriate for use as a miRNA reference gene in
early gestational tissues of the pig. While all genes had a fairly
narrow range of Cps, several of the putative reference genes had
significant differences across the tissues of interest. RNU5A, RNU6B,
SCARNA17,a n dSNORA73A are thus not appropriate miRNA
reference genes in early pig gestational tissues. The fourth criterion
was a single melting peak and melting temperature of approxi-
mately 74–77uC. Again, all six genes met this criterion. The fifth
criterion was to have the gene sequence confirmed by sequencing
the PCR product, to ensure the correct gene transcript was being
isolated. The sixth criterion was an M value of #1.5 as determined
bygeNormsoftware [26].Again,allsixgenesmetthiscriterion.The
seventh criterion was a low inter- and intra-group variation and
stability value as determined by NormFinder software [27]. All six
genes met this criterion. As all six genes appeared to isolate a single,
specific PCR product, any of them could be used as a miRNA
reference gene in the pig, provided they are stably expressed across
the tissues of interest.
The most stably expressed reference genes in pig reproductive
tissues from both healthy and arresting attachment sites were
RNU1A, SNORA73A, and SNORD25, according to geNorm,
NormFinder, and regression analysis. Both geNorm and Norm-
Finder algorithms recommended the use of RNU1A/SNORA73A,
and RNU1A/SNORD25 respectively, as the most stable pair of
reference genes to normalize expression data. However, out of
these three genes, both SNORA73A and SNORD25 were shown to
be inappropriate reference genes during early porcine gestation.
As a consequence of not specifically measuring the inter-tissue
variation geNorm inappropriately selected SNORA73A as part of
the most stable pair of reference genes, even though statistically
significant differences between the tissue types were demonstrated
by ANOVA and its specific PCR product could not be confirmed.
NormFinder selected a combination of RNU1A/SNORD25 to
represent the most stable pair of reference genes for miRNA
expression studies by real time PCR during early gestation in the
pig. However, when SNORD25 was used as a reference gene to
measure miR-331-5p expression between healthy endometrium
and trophoblast, an artificial significance not seen in microarray
data from the same tissue set, was observed. Indeed, the selection
of an inappropriate reference gene had the ability to artificially
influence the relative quantity of both miR-331-5p and miR-339-3p.
Figure 5. Normalizing Target Genes to the Two Most Stable
Reference Genes: RNU1A/SNORD25. Fold change for miR-331-5p and
miR-339-3p between healthy endometrium (HE) and trophoblast (HT)
were calculated using the geometric mean of RNU1A/SNORD25 and the
ddCt method. HE was compared to HT for each target gene
independently by t-test. When the most stable pair of references genes
predicted by geNorm and NormFinder algorithms was used as a
normalizer, no significant differences in miRNA expression were
observed between HE and HT. HE samples were arbitrarily set to a
value of 1 + SEM (as a percentage of the variation among biological
replicates), HT samples show the fold change above or below HE + SEM.
Dark grey bars: healthy endometrium (n=3), light grey bars: healthy
trophoblast (n=3).
doi:10.1371/journal.pone.0028940.g005
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RNU1A/SNORD25 were used as the normalizing factor. However,
when comparing the sensitivity of the ratio of target to reference
produced by the LightCycler software, to the fold change
manually calculated, the former appeared to have a greater
sensitivity to small differences. This is important because the
difference in miRNA levels between experimental samples can be
very small, yet still biologically meaningful [10,22].
Although several studies suggest the use of one to three
validated reference genes for each individual experiment [26,27],
others demonstrate that one gene may be sufficient for certain
experimental situations [10]. As two of the three genes predicted
by geNorm and NormFinder were demonstrated in this report to
be unstably expressed across porcine reproductive tissues
(SNORA73A, and SNORD25), and the stability value of RNU1A/
SNORD25 was only marginally lower than that of RNU1A alone, it
appears appropriate to use RNU1A as a reference gene for miRNA
expression studies during early pregnancy in the pig.
The results of this study indicate the cross-reactivity of all six
human miRNA reference primers in pig reproductive tissues. Each
of these genes has the potential to be used as a porcine miRNA
reference gene provided it is validated and stably expressed in the
experimental tissues of choice. SNORA73A PCR product remains
to be confirmed by sequencing, but the primer is likely isolating a
specific product based on melting curve analysis, and gel
electrophoresis. The results of this study also demonstrate that
reference gene expression can vary between tissue types.
Therefore, the selection of a validated and appropriate reference
gene(s) for each experiment is the optimal strategy for minimizing
errors of measurement in miRNA expression studies. Four of the
six reference genes examined were not appropriate for miRNA
studies during early gestation in the pig. If two reference genes are
absolutely required, RNU1A/SNORD25 are recommended. How-
ever, if one reference gene is required, RNU1A is the most stably
expressed reference gene for the real time PCR quantification of
miRNAs during early porcine gestation, as determined by Cp/
PCR analysis, geNorm, NormFinder, and testing against stably
expressed target genes.
Materials and Methods
Sample Collection
First to third parity, specific pathogen-free Yorkshire sows were
used for this study (University of Guelph, Guelph, ON, Canada).
The Animal Care Committee of the University of Guelph
approved all procedures (Animal utilization protocol number
10RO61). Sows were checked daily for estrus using an intact boar.
At estrus, sows were placed in stalls and bred by artificial
insemination using fresh pooled semen. Sows were re-bred
24 hours later. At gestation day 20 (gd20), sows were euthanized
(n=3). Reproductive tracts were collected at the University of
Guelph abattoir and transported to the laboratory on ice. The
uteri were cut longitudinally along the anti-mesometrial side to
expose conceptuses. One healthy, and one arresting conceptus
were selected per sow, based on disparity in size and vascularity as
previously described [24,25,33]. Paired samples of mesometrial
endometrium and trophoblast were collected from each gd20
attachment site. Non-pregnant samples were collected from
random, mesometrial endometrial sites from mid-estrus sows
(n=4). Samples were immediately frozen and stored at 280uC.
miRNA Extraction
Samples were thawed on ice, and total RNA including miRNA
was extracted from all samples using miRNeasy mini kit (Qiagen,
Mississauga, ON, Canada) according to the manufacturer’s
directions. Briefly, 30 mg of frozen tissue was placed in 700 mlo f
QIAzol lysis reagent from the kit, and disrupted using a rotor-stator
homogenizer and Kontes pestles (Fisher Scientific, Ottawa, ON,
Canada) for 30 seconds at room temperature. The mixture was
allowed to sit for 5 min, and 140 ml of chloroform (Fisher Scientific,
Ottawa, ON, Canada) was added to the tube. Tubes were
vigorously shaken by vortex for 15 seconds and allowed to settle
for 3 minutes at room temperature. Samples were centrifuged at
4uC at 12000 g for 15 minutes. The aqueous phase of the mixture
was added to 525 ml of 100% ethanol (University of Guelph,
Guelph, ON, Canada) and pipetted several times to mix. The
mixture was then transferred to an RNeasy mini spin column, and
spun at 8000 g for 15 seconds, at room temperature. The flow-
through was discarded. The columns were washed with 700 mlo f
Buffer RWT, and centrifuged at 8000 g for 15 seconds followed by
wash in 500 ml of Buffer RPE. Flow-through was discarded. Finally,
columns weretransferred tonewcollectingtubes providedinthekit,
and 30 ml of DNase/RNase free water (Gibco, Burlington, ON,
Canada) was added directly on the column membrane and toral
RNA was eluted by centrifugation at 8000 g for 1 minute. The
concentration and purity of the RNA extracted was measured using
the GeneQuant pro RNA/DNA calculator (Biochrom Ltd.,
Cambridge, UK). Total RNA was stored at 280uC until required.
miRNA cDNA Preparation
Total RNA including miRNA from each sample was reverse
transcribed using the miScript Reverse Transcription kit (Qiagen,
Mississauga, ON, Canada) as per the manufacturer’s protocol.
Briefly, a master mix of 4 ml of miScript RT Buffer, and 1 mlo f
miScript Reverse Transcriptase Mix per tube was prepared and
distributed to 0.2 mL PCR tubes (UltiDent Scientific, St. Laurent,
QC, Canada) on ice. DNase/RNase free water was added to 1 mg
of RNA to bring the volume to 15 ml. The RNA was added to the
PCR tube, bringing the final volume to 20 ml. Samples were
incubated at 37uC for 60 minutes and at 95uC for 5 minutes. The
reaction mixture was placed on ice and diluted with 150 mlo f
DNase/RNase free water. The concentration and purity of the
cDNA was measured using the GeneQuant pro RNA/DNA
calculator. cDNA was stored at 280uC until required.
Reference and Target Genes
All six reference genes (RNU1A, RNU5A, RNU6B, SNORD25,
SCARNA17, and SNORA73A) were selected based on the
availability of commercial primers. They are all short, non-coding
RNAs of roughly 150 bp in length [33], and are marketed for use
in human, mouse, rat, and dog tissues by Qiagen (Qiagen,
Mississauga, ON, Canada). Gene short forms, full names, and
estimated product sizes are listed in Table 1.
Primers for porcine-specific target genes ssc-miR-331-5p and ssc-
miR-339-3p were custom designed using sequences available in the
miRBase version 16 [34], and ordered from Qiagen (Qiagen,
Mississauga, ON, Canada). These genes were selected because of
their stability between healthy endometrium and healthy tropho-
blast, as determined in the same experimental tissue set by
microarray [unpublished].
Real Time PCR
Primers for all six candidate and two target genes (Qiagen,
Mississauga, ON, Canada) were diluted according to the
manufacturer’s protocol. A pool of miRNA cDNA was created
using all samples. An initial real time PCR to test the primers was
performed on pooled miRNA cDNA in triplicate using the
miScript SYBR Green PCR kit (Qiagen, Mississauga, ON,
Validation of miRNA Reference Genes
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Laval, QC, Canada). The PCR conditions were set according to
manufacturer’s protocols (activation: 95uC; 15 minutes, 45 cycles
of denaturation: 94uC; 15 sec., annealing: 55uC; 30 sec., and
extention 70uC; 30 sec., melting curve: 70–95uC at a rate of 0.1uC
per second). Products for each gene were serially diluted ten-fold
to create a standard curve.
Each of the six candidate genes was measured in duplicate in all
sixteen samples (n=3 gd20 Healthy Endometrium (HE), n=3 gd20
Arresting Endometrium(AE),n=3 gd20HealthyTrophoblast (HT),
n=3 gd20 Arresting Trophoblast (AT), and n=4 Non-Pregnant
Endometrium (NP)) by 384 well, plate-based real-time PCR (LC480,
Roche Diagnostics, Laval, QC, Canada). Cp values were measured
by LightCycler 480 software (release 1.5.0 SP3, Roche Diagnostics,
Laval, QC, Canada) and averaged by tissue type. Target genes miR-
331-5p and miR-339-3p were also measured in duplicate in the same
HE and HT samples (n=3 gd20 HE, n=3 gd20 HT). Standard
curves for each gene and an RT-negative control were also included
on the plate. The PCR conditions were identical to those used in the
capillary-based system, except for the melting curve: 65–97uCa ta
rate of 2.5uC per second. After the generation of 10-fold dilution
series standard curves, the PCR efficiency was calculated for each
reference gene using the LightCycler 480 software (Roche
Diagnostics, Laval, QC, Canada). Several dilutions were then
excluded from the standard curve to optimize PCR efficiency.
Melting curve analysis was performed to ensure amplification of only
one product and to ensure products melted in the appropriate range
for miRNAs (,74–77uC, according to the manufacturer: Qiagen,
Mississauga, ON, Canada). Finally, PCR products were run on a
0.5% agarose gel to estimate product size.
Cloning and Sequencing
Fresh PCR product was used for cloning to confirm primer
specificity. All PCR products were inserted into plasmid vectors
using the topoisomerase-TA cloning kit (Invitrogen Life Technol-
ogies, Burlington, ON, Canada) as per manufacturer’s instruc-
tions. Bacterial colonies were grown at 37uC on LB media
containing ampicillin, then transferred to liquid LB. Plasmid DNA
was purified using the Genelute Plasmid Mini-Prep Kit (Sigma, St.
Louis, MO, USA). Plasmids were then sent for sequencing at the
Laboratory Services Division of the University of Guelph. Each
sequence underwent BLASTN analysis on the National Center for
Biotechnology Information website. Sequences were submitted to
NCBI GenBank (RNU1A: JN617883; RNU5A: JN617884; RNU6B:
JN617885; SNORD25: JN646111; SCARNA17: JN617886; ssc-miR-
331-5p: JN646112; and ssc-miR-339-3p: JN646113). If the gene
product could not be positively identified, cloning was repeated
two more times.
Data Analysis
Cps (from LightCycler software) were imported into geNorm
software (http://medgen.ugent.be/,jvdesomp/genorm/) [26]
and the expression stability of each reference gene was evaluated.
M values represent the combined variation within the experimen-
tal group and between reference genes. Genes with the lowest M
value have the most stable expression. V values were calculated to
determine the optimal number of reference genes to use for
subsequent quantifications.
Average Cps were converted into relative quantities (RQ) for
NormFinder (http://www.mdl.dk/publicationsnormfinder.htm)
analysis following the methods in Latham, 2010 [9]. The
NormFinder algorithm independently estimates the inter- and
intra-group variance, and provides a stability value for each
reference gene. Genes with the lowest stability value have the most
stable expression [27]. The correlation between the geNorm M
value and the NormFinder Stability Value was evaluated by the
coefficient of determination (R
2) (SigmaPlot 10.0, Systat Software
Inc., Chicago, IL, USA).
To determine reference gene stability across the experimental
panel of samples, data was analyzed by one-way ANOVA
(SigmaPlot 10.0, Systat Software Inc., Chicago, IL, USA), and
the average expression level (as a Cp) and SEM for each reference
gene were calculated and plotted. For all statistical tests, a p value
of ,0.05 was considered significant.
The relative quantification of each target gene against each
reference gene was calculated using LC480 software (release 1.5.0
SP3, Roche Diagnostics, Laval, QC, Canada). The fold change for
each target gene was calculated using the geometric mean of
RNU1A/SNORD25 as a normalizer and the ddCt method
[9,35,36]. HE samples were arbitrarily set to a value of 1 +
SEM (as a percentage of the variation among biological replicates),
HT samples show the fold change above or below HE + SEM . T-
tests were used to determine statistical significance between HE
and HT samples.
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